INTRASENSE SAS (ALINS.PA) Stock Overview
Europe - EPA:ALINS - FR0011179886 - Common Stock
ALINS.PA Key Statistics, Chart & Performance
The current stock price of ALINS.PA is 0.276 EUR. In the past month the price decreased by -6.12%. In the past year, price increased by 0.73%.
ALINS.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| NXU.DE | NEXUS AG | 36.01 | 1.23B | ||
| EQS.PA | EQUASENS | 16.23 | 588.60M | ||
| GPI.MI | GPI SPA | 22.85 | 495.52M | ||
| CONTX.OL | CONTEXTVISION AB | 34.62 | 348.17M | ||
| ALCGM.PA | CEGEDIM SA | N/A | 173.43M | ||
| AGFB.BR | AGFA-GEVAERT NV | N/A | 131.29M | ||
| ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 110.52M | ||
| AJ91.DE | DOCCHECK AG | 11.92 | 62.87M | ||
| M3V.DE | MEVIS MEDICAL SOLUTIONS AG | 10.24 | 46.59M |
Related stock screener links
About ALINS.PA
Company Profile
Intrasense SA engages in the design and development of advanced software solutions for viewing and analyzing of medical images. The company is headquartered in Montpellier, Occitanie and currently employs 76 full-time employees. The company went IPO on 2012-02-22. The Company’s activities are divided into three divisions: sales of software for viewing and analyzing medical images; development of peripheral solutions;and supply of services. Its product portfolio comprises the Myrian line products are integrated into existing medical devices, such as Cr, Ultra sound and Nuclear imagining. Myrian Solutions are used for reconstruction of images from the Computed tomography(CT) scan, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography scans, marketed under Myrian brand. The peripheral solutions provide materials for viewing digital images in the operating room, as well as various equipment, including printing servers and workstations, among others. The company offers also support, maintenance, as well as software rental and installation services for its products.
Company Info
INTRASENSE SAS
1231 Avenue du Mondial 98
Montpellier OCCITANIE FR
Employees: 76
Phone: 33467130130
INTRASENSE SAS / ALINS.PA FAQ
Can you describe the business of INTRASENSE SAS?
Intrasense SA engages in the design and development of advanced software solutions for viewing and analyzing of medical images. The company is headquartered in Montpellier, Occitanie and currently employs 76 full-time employees. The company went IPO on 2012-02-22. The Company’s activities are divided into three divisions: sales of software for viewing and analyzing medical images; development of peripheral solutions;and supply of services. Its product portfolio comprises the Myrian line products are integrated into existing medical devices, such as Cr, Ultra sound and Nuclear imagining. Myrian Solutions are used for reconstruction of images from the Computed tomography(CT) scan, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography scans, marketed under Myrian brand. The peripheral solutions provide materials for viewing digital images in the operating room, as well as various equipment, including printing servers and workstations, among others. The company offers also support, maintenance, as well as software rental and installation services for its products.
What is the stock price of INTRASENSE SAS today?
The current stock price of ALINS.PA is 0.276 EUR. The price increased by 2.22% in the last trading session.
Does ALINS stock pay dividends?
ALINS.PA does not pay a dividend.
How is the ChartMill rating for INTRASENSE SAS?
ALINS.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the market expecting ALINS stock to perform?
7 analysts have analysed ALINS.PA and the average price target is 0.24 EUR. This implies a price decrease of -11.3% is expected in the next year compared to the current price of 0.276.
How is the valuation of INTRASENSE SAS (ALINS.PA) based on its PE ratio?
INTRASENSE SAS (ALINS.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.12).
When does INTRASENSE SAS (ALINS.PA) report earnings?
INTRASENSE SAS (ALINS.PA) will report earnings on 2026-03-23.
ALINS.PA Technical Analysis
ALINS.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ALINS.PA. ALINS.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
ALINS.PA Financial Highlights
Over the last trailing twelve months ALINS.PA reported a non-GAAP Earnings per Share(EPS) of -0.12. The EPS decreased by -63.91% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -73.59% | ||
| ROE | -341.9% | ||
| Debt/Equity | 0.54 |
ALINS.PA Forecast & Estimates
7 analysts have analysed ALINS.PA and the average price target is 0.24 EUR. This implies a price decrease of -11.3% is expected in the next year compared to the current price of 0.276.
For the next year, analysts expect an EPS growth of 37.5% and a revenue growth 71.49% for ALINS.PA